Literature DB >> 12639555

Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir.

Takeshi Masuda1, Satoshi Shibuya, Masami Arai, Shuku Yoshida, Takanori Tomozawa, Akiko Ohno, Makoto Yamashita, Takeshi Honda.   

Abstract

We synthesized bicyclic ether sialidase inhibitors such as tetrahydro-furan-2-yl, tetrahydro-pyran-2-yl, and oxepan-2-yl derivatives related to zanamivir. These compounds substituted by diol at the C-3' and C-4' positions resulted in the retention of low nanomolar inhibitory activities against not only influenza A virus sialidase but also influenza A virus in cell culture. Compound 11a in particular showed comparable efficacy in vivo relative to that of oseltamivir phosphate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639555     DOI: 10.1016/s0960-894x(02)01039-9

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Consensus QSAR model for identifying novel H5N1 inhibitors.

Authors:  Nitin Sharma; Chun Wei Yap
Journal:  Mol Divers       Date:  2012-07-21       Impact factor: 2.943

2.  Syntheses of Legionaminic Acid, Pseudaminic Acid, Acetaminic Acid, 8-epi-Acetaminic Acid, and 8-epi-Legionaminic Acid Glycosyl Donors from N-Acetylneuraminic Acid by Side Chain Exchange.

Authors:  Sameera Siyabalapitiya Arachchige; David Crich
Journal:  Org Lett       Date:  2022-04-14       Impact factor: 6.072

Review 3.  Anti-influenza virus agents: synthesis and mode of action.

Authors:  Irene M Lagoja; Erik De Clercq
Journal:  Med Res Rev       Date:  2008-01       Impact factor: 12.944

Review 4.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 5.  Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance.

Authors:  Jennifer L McKimm-Breschkin
Journal:  Treat Respir Med       Date:  2005

Review 6.  Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses.

Authors:  Aarthi Narayanan; Charles Bailey; Fatah Kashanchi; Kylene Kehn-Hall
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.498

Review 7.  Current and future antiviral therapy of severe seasonal and avian influenza.

Authors:  John Beigel; Mike Bray
Journal:  Antiviral Res       Date:  2008-02-04       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.